Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

News from ICAAC 2013

News from ICAAC 2013

, by Liz Highleyman

An overview of key research—from gene therapy findings to new and evolving HIV treatment options—presented at this year's Interscience Conference on Antimicrobial Agents and Chemotherapy. Read More

Cure Research at IAS 2013

Cure Research at IAS 2013

, by Liz Highleyman

Promising findings, lingering questions, and next steps presented at this month’s International AIDS Society Conference in Kuala Lumpur. Read More

PrEP News from IAS 2013

PrEP News from IAS 2013

, by Liz Highleyman

Studies presented in Kuala Lumpur shed further light on pre-exposure prophylaxis for gay men, women, and people who inject drugs. Read More

Studies at IAS 2013 Look at ART Side Effects

Studies at IAS 2013 Look at ART Side Effects

, by Liz Highleyman

Modern HIV meds are more tolerable than older drugs, but even the most widely used can lead to problems for some individuals. Read More

Antiretroviral Therapy News from IAS 2013

Antiretroviral Therapy News from IAS 2013

, by Liz Highleyman

Learn about the HIV treatment refinements—including lower drug doses and monthly injections vs. daily pills—described at last week’s conference in Kuala Lumpur. Read More